04/07/2025
2:42 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
4:19 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
9:30 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
3:45 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEF 14A | |
04/01/2025
4:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/27/2025
6:17 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2025
4:11 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:10 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
CHEMEROW DAVID I. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:10 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
8:36 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
9:00 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for HEB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Hemispherx BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
03/04/2025
1:14 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
12:14 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:45 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form PRE 14A | |
02/28/2025
7:00 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
7:45 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
7:50 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
7:35 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
8:24 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1/A | |
02/07/2025
7:55 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
7:30 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
3:05 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
8:09 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1/A | |
01/23/2025
4:26 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/21/2025
3:32 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:30 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
2:23 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
KELLNER TED D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/23/2024
10:11 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SCHEDULE 13D/A | |
12/20/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:30 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
12:38 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:41 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/16/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/16/2024
3:59 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/13/2024
3:43 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/12/2024
3:49 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/12/2024
3:09 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/11/2024
7:52 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/10/2024
3:39 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/10/2024
8:01 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
Trump’s Top Secret $9 Trillion AI Superweapon (Ad) Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that could benefit. Nvidia’s early days made millionaires. This AI play might too. |
12/10/2024
8:06 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/09/2024
4:25 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/06/2024
3:50 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/05/2024
3:37 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/03/2024
5:29 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:33 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:36 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:55 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/02/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/27/2024
4:26 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/27/2024
3:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/26/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/25/2024
4:16 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/22/2024
4:26 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/21/2024
11:02 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
11:04 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
11:46 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/14/2024
3:25 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/14/2024
2:21 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
11/06/2024
8:02 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DEFC14A | |
11/04/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/04/2024
6:00 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
| Form DEFC14A | |
10/30/2024
3:50 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form PRER14A | |
10/30/2024
11:53 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form PRRN14A | |
10/18/2024
3:34 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form PREC14A | |
10/15/2024
3:33 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
| Form PREC14A | |
10/01/2024
2:55 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
12:12 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
09/30/2024
7:22 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
09/17/2024
11:05 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
2:45 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:15 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:45 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
4:40 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
09/03/2024
8:43 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
08/14/2024
6:37 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
08/12/2024
8:39 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:41 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
5:05 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:14 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
07/25/2024
11:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form EFFECT | |
07/25/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
07/15/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
4:19 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
07/11/2024
4:16 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/03/2024
9:15 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
9:05 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
05/31/2024
7:14 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
Trump’s Top Secret $9 Trillion AI Superweapon (Ad) Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that could benefit. Nvidia’s early days made millionaires. This AI play might too. |
05/07/2024
7:30 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:30 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
11:16 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form EFFECT | |
05/01/2024
3:35 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
Buy HEB Stock Free HEB Stock Alerts